Skip to content
value.today

mPharma Data, Inc

Total raised
$47 M
4 rounds on record
Latest round
$14 M
Dec 2023
First round on record
Dec 2015
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of mPharma Data, Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2023$14 MNo. 4$10 to $50 million

mPharma Data, Inc: Raise no. 4, Dec 2023

Investors in this round

22 investors had bought by the notice of Jan 30, 2024: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Shoukimas · Executive Officer
  • Gregory Rockson · Executive Officer, Director
  • Joanna Lee Shevelenko · Director
  • Philip Sowah · Director
  • Shravin Mittal · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gregory Rockson, Ceo. Source: SEC Form D, newest notice filed Jan 30, 2024. Read the notice at the SEC.

equitySEC
Jan 2020$19 MNo. 3$10 to $50 million

mPharma Data, Inc: Raise no. 3, Jan 2020

Investors in this round

17 investors had bought by the notice of Apr 13, 2020: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $22 M offered; $3 M still to sell
Smallest investment taken
$15,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Shoukimas · Executive Officer
  • Gregory Rockson · Executive Officer, Director
  • James Nishiyama Finucane · Executive Officer
  • Nana Dufie Addo · Executive Officer
  • Sophia Dufie Baah · Executive Officer
  • Andrew Nishiyama Carruthers · Director
  • Daniel Nishiyama Vasella · Director
  • Joanna Lee Nishiyama Shevelenko · Director
  • Philip Sowah · Director
  • Sangu Julius Delle · Director
  • Shravin Mittal · Director
  • Walter Nishiyama Baddoo · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gregory Rockson, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Apr 13, 2020. Read the notice at the SEC.

equitySEC
Dec 2018$10 MNo. 2$2 to $10 million

mPharma Data, Inc: Raise no. 2, Dec 2018

Investors in this round

18 investors had bought by the notice of Jan 10, 2019: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $12 M offered; $2 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Shoukimas · Executive Officer
  • Dufie Addo · Executive Officer
  • Gregory Rockson · Executive Officer, Director
  • James Nishiyama Finucane · Executive Officer
  • Sophia Baah · Executive Officer
  • Philip Sowah · Director
  • Sangu Julius Delle · Director
  • Shravin Mittal · Director
  • Walter Nishiyama Baddoo · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gregory Rockson, Ceo. Source: SEC Form D, newest notice filed Jan 10, 2019. Read the notice at the SEC.

equitySEC
Dec 2015$5 MNo. 1$2 to $10 million

mPharma Data, Inc: Raise no. 1, Dec 2015

Investors in this round

14 investors had bought by the notice of Jan 28, 2016: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$20,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Shoukimas · Executive Officer
  • Gregory Rockson · Executive Officer, Director
  • James Finucane · Executive Officer
  • Amir Lahat · Director
  • Mayer Gniwisch · Director
  • Philip Sowah · Director
  • Sangu Delle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gregory Rockson, Ceo. Source: SEC Form D, newest notice filed Jan 28, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • mPharma Data, Inc chose not to state its revenue in its newest notice of a funding round (Jan 2024).

    SEC Form D · Jan 2024

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Jan 2024

That is all the official record says: mPharma Data, Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of mPharma Data, Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 22 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by mPharma Data, Inc
NameRoleNamed in
Daniel ShoukimasExecutive officerJan 2024
Gregory RocksonExecutive officerJan 2024
James Nishiyama FinucaneExecutive officerApr 2020
Nana Dufie AddoExecutive officerApr 2020
Sophia Dufie BaahExecutive officerApr 2020
Dufie AddoExecutive officerJan 2019
Sophia BaahExecutive officerJan 2019
James FinucaneExecutive officerJan 2016
Gregory RocksonDirectorJan 2024
Joanna Lee ShevelenkoDirectorJan 2024
Philip SowahDirectorJan 2024
Shravin MittalDirectorJan 2024
Andrew Nishiyama CarruthersDirectorApr 2020
Daniel Nishiyama VasellaDirectorApr 2020
Joanna Lee Nishiyama ShevelenkoDirectorApr 2020
Sangu Julius DelleDirectorApr 2020
Walter Nishiyama BaddooDirectorApr 2020
Amir LahatDirectorJan 2016
Mayer GniwischDirectorJan 2016
Sangu DelleDirectorJan 2016